Select Medical Holdings Corporation
SEM
$17.90
-$0.27-1.49%
| Weiss Ratings | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.83 | |||
| Price History | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.91% | |||
| 30-Day Total Return | -6.84% | |||
| 60-Day Total Return | -9.38% | |||
| 90-Day Total Return | 2.48% | |||
| Year to Date Total Return | -4.41% | |||
| 1-Year Total Return | 18.80% | |||
| 2-Year Total Return | 32.37% | |||
| 3-Year Total Return | 48.95% | |||
| 5-Year Total Return | 62.88% | |||
| 52-Week High % Change | -55.66% | |||
| 52-Week Low % Change | 12.16% | |||
| Price | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $40.98 | |||
| 52-Week Low Price | $16.20 | |||
| 52-Week Low Price (Date) | Feb 21, 2025 | |||
| 52-Week High Price (Date) | Nov 11, 2024 | |||
| Valuation | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.34B | |||
| Enterprise Value | 5.30B | |||
| Price/Earnings (TTM) | 10.95 | |||
| Earnings Per Share (TTM) | 1.66 | |||
| Earnings Per Share Growth | -15.38% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.35 | |||
| Price/Book (Q) | 1.39 | |||
| Enterprise Value/Revenue (TTM) | 0.80 | |||
| Price | $17.90 | |||
| Enterprise Value/EBITDA (TTM) | 7.39 | |||
| Enterprise Value/EBIT | 10.32 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 125.92M | |||
| Dividend Yield | 2.41% | |||
| Div. Per Share (Most Recent) | $0.06 | |||
| Dividend Per Share (TTM) | $0.44 | |||
| Payout Ratio (TTM) | 30.19% | |||
| Dividend Per Share (Most Recent) | $0.06 | |||
| Company Info | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 717 972 1100 | |||
| Address | 4714 Gettysburg Road Mechanicsburg, PA 17055 | |||
| Website | www.selectmedical.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.76% | |||
| Profit Margin | 3.23% | |||
| Management Effectiveness | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.83% | |||
| Return on Equity | 15.82% | |||
| Income Statement | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 6.62B | |||
| Total Revenue (TTM) | 6.62B | |||
| Revenue Per Share | $52.59 | |||
| Gross Profit (TTM) | 1.23B | |||
| EBITDA (TTM) | 717.89M | |||
| EBIT (TTM) | 513.99M | |||
| Net Income (TTM) | 214.04M | |||
| Net Income Avl. to Common (TTM) | 214.04M | |||
| Total Revenue Growth (Q YOY) | 832.36% | |||
| Earnings Growth (Q YOY) | 91.80% | |||
| EPS Diluted (TTM) | 1.66 | |||
| EPS Diluted Growth (Q YOY) | -129.74% | |||
| Balance Sheet | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 59.69M | |||
| Cash Per Share (Q) | $0.47 | |||
| Total Current Assets (Q) | 1.02B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.00B | |||
| Current Ratio (Q) | 1.043 | |||
| Book Value Per Share (Q) | $13.04 | |||
| Total Assets (Q) | 5.61B | |||
| Total Current Liabilities (Q) | 977.65M | |||
| Total Debt (Q) | 2.70B | |||
| Total Liabilities (Q) | 3.61B | |||
| Total Common Equity (Q) | 1.68B | |||
| Cash Flow | SEM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -231.01M | |||
| Cash from Financing (TTM) | -311.17M | |||
| Net Change in Cash (TTM) | -24.31M | |||
| Levered Free Cash Flow (TTM) | 329.10M | |||
| Cash from Operations (TTM) | 517.86M | |||
